The cash flow of Disc Medicine, Inc. over the past 6 years
Chart Disc Medicine, Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2020–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Disc Medicine, Inc.'s operating cash flow was -$180.39M and its capital expenditures $933K, leaving free cash flow of -$181.33M. Free cash flow was below zero in all 6 years shown. It ranged from -$181.33M in fiscal 2025 to -$27.6M in fiscal 2021. Capital expenditures were highest in fiscal 2025, at $933K.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$180.39M | $933K | -$181.33M |
| 2024ended Dec 31, 2024 | -$93.93M | $505K | -$94.43M |
| 2023ended Dec 31, 2023 | -$73.46M | $89K | -$73.55M |
| 2022ended Dec 31, 2022 | -$42.25M | $151K | -$42.4M |
| 2021ended Dec 31, 2021 | -$27.53M | $68K | -$27.6M |
| 2020ended Dec 31, 2020 | -$32.71M | $22K | -$32.73M |
Fiscal years as Disc Medicine, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Disc Medicine, Inc.
- The profitability of Disc Medicine, Inc.
- The debt of Disc Medicine, Inc.
- All of Disc Medicine, Inc.'s financials, charted
Companies of a similar size
- NMRKNEWMARK GROUP, INC.
- ATRCAtriCure, Inc.
- GPIGroup 1 Automotive, Inc
- TMDXTransMedics Group, Inc.
- KSSKOHL’S CORP
Not investment advice. This page shows what Disc Medicine, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.